Feature|Articles|November 11, 2023
- Pharmaceutical Executive: November 2023
- Volume 43
- Issue 11
Pharmaceutical Executive: November 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
2024 Pipeline Report: First-World Focusalmost 2 years ago
Pharma Should Embrace the Single Sign-Onalmost 2 years ago
22nd Annual Industry Audit: The Pharma Value Picturealmost 2 years ago
Changing the Paradigm in AI Implementationalmost 2 years ago
Reading the Tea Leaves for Biotech As 2024 Approachesalmost 2 years ago
Pharma Giving is Still Strong Despite Post-Pandemic Shiftsalmost 2 years ago
Equity for Women in Healthcare: 131 Years is Too Long to Waitalmost 2 years ago
A Peek at PotentialNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
